Form 13-F position report

IMMUNIC INC COM (DE)

Reported by CITADEL ADVISORS LLC

Company profile Manager portfolio Source filing
IMUX CUSIP 4525EP101 Manager CIK 0001423053
Latest reported change

First reported at 535,083 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q3 2025
Shares 535,083 Quarter-end amount reported
Reported value $471,729 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q2 2026 Reduced 0 -114,487 (-100.0%) 0 $0 2026-08-14
Q1 2026 Reduced 114,487 -152,319 (-57.1%) < 0.01% $127,081 2026-05-15
Q4 2025 Reduced 266,806 -268,277 (-50.1%) < 0.01% $142,394 2026-02-17
Q3 2025 New 535,083 +535,083 (0.0%) < 0.01% $471,729 2025-11-14
Q1 2025 Reduced 0 -300 (-100.0%) 0 $0 2025-05-15
Q4 2024 Reduced 300 -239,757 (-99.9%) < 0.01% $300 2025-02-14
Q3 2024 Added 240,057 +240,055 (12002750.0%) < 0.01% $396,094 2024-11-14
Q2 2024 Unchanged 2 0 (0.0%) < 0.01% $2 2024-08-14
Q1 2024 New 2 +2 (0.0%) < 0.01% $3 2024-05-15
Q3 2023 Reduced 0 -1,879 (-100.0%) 0 $0 2023-11-14
Q2 2023 Reduced 1,879 -6,101 (-76.5%) < 0.01% $4,716 2023-08-14
Q1 2023 Reduced 7,980 -17,224 (-68.3%) < 0.01% $11,890 2023-05-15
Q4 2022 New 25,204 +25,204 (0.0%) < 0.01% $35,286 2023-02-14
Q3 2022 Reduced 0 -496,554 (-100.0%) 0 $0 2022-11-14
Q2 2022 Added 496,554 +462,178 (1344.5%) < 0.01% $1,723,000 2022-08-15
Q1 2022 Reduced 34,376 -10,236 (-22.9%) < 0.01% $389,000 2022-05-16
Q4 2021 New 44,612 +44,612 (0.0%) < 0.01% $427,000 2022-02-14
Q3 2021 Reduced 0 -13,909 (-100.0%) 0 $0 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

70 managers reported IMMUNIC INC COM (DE) for Q3 2025.

Manager Activity Shares Change % of reported 13F Reported value Tenure
abrdn plc Unchanged 8,243,941 0 0.01% $7,267,858 3 qtrs
BVF INC IL Unchanged 7,652,972 0 0.27% $6,746,860 12 qtrs
Avidity Partners Management LP Reduced 4,699,411 -916,400 0.94% $4,143,001 7 qtrs
VANGUARD GROUP INC Added 4,345,105 +219,957 < 0.01% $3,832,383 26 qtrs
MORGAN STANLEY Reduced 3,103,121 -525,406 < 0.01% $2,735,711 26 qtrs
Focus Partners Wealth Added 2,581,587 +39,063 < 0.01% $2,275,927 5 qtrs
Laurion Capital Management LP Reduced 1,882,162 -22,901 0.03% $1,659,314 3 qtrs
Soleus Capital Management L P Reduced 1,580,007 -5,713,000 0.07% $1,392,934 16 qtrs
ADAGE CAPITAL PARTNERS GP L L C Unchanged 1,398,600 0 < 0.01% $1,233,006 7 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,033,772 +59,136 < 0.01% $911,653 22 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
535,083
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.